The US Food and Drug Administration kept up a blistering pace of new drug approvals last year, all while navigating the urgent evaluation of tests, drugs, and vaccines in development for COVID-19. The ...
These new drug approvals are listed below, starting with the most recent: 1. Orgovyx was approved Dec. 18 as the first oral hormone therapy for adults with advanced prostate cancer. 2. Margenza was ...